Long-Term Safety and Disease Control of Ruxolitinib Cream Among Adolescents With Atopic Dermatitis: Results From Two Phase 3 Studies [PDF]
, 2022 Lawrence Eichenfeld +10 more
openalex +1 more source
Novel methods of treating atopic dermatitis [PDF]
Atopic dermatitis is a long-term inflammatory skin disease caused by factors such as skin barrier dysfunction and immune system dysregulation . Currently, the first-line treatment for atopic dermatitis involves the use of topical glucocorticosteroids ...
Choinka, Martyna +7 more
core +1 more source
50342 Serum Protein Biomarkers May Reveal Clues to Early Immune Activity Upon Ruxolitinib Cream Withdrawal in the TRuE-V Long-Term Extension Study [PDF]
Angelina Volkova +7 more
openalex +1 more source
Effects of Ruxolitinib Cream in Patients With Atopic Dermatitis With Head and/or Neck Involvement [PDF]
, 2021 Eric L. Simpson +5 more
openalex +1 more source
British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018 [PDF]
, 2018 Affleck, A.G. +16 more
core +1 more source
Recalcitrant multi-variant lichen planus successfully treated with oral baricitinib and topical ruxolitinib cream [PDF]
Mildred Min +2 more
openalex +1 more source
Trichodysplasia Spinulosa related to Ruxolitinib: A Case Report [PDF]
, 2023 Rosa-Nieves, Priscilla M., et. al.
core +2 more sources
Modern treatment methods in atopic dermatitis - literature overview [PDF]
Introduction and aim: Atopic dermatitis (AD) is a chronic inflammatory skin disease. It is characterised by periods of exacerbation and remission of symptoms such as pruritus, dry skin and eczematous lesions with characteristic morphology.
Biłogras, Jan +6 more
core +1 more source